Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00127153 | A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013) | PHASE3 | COMPLETED | 130 | — | — | Mar 1, 2005 | May 1, 2005 | Jan 29, 2015 | - | — |
| Name | Type | Description |
|---|---|---|
| V110, pneumococcal vaccine polyvalent | BIOLOGICAL | - |
Inclusion Criteria: * Males and females in good health, ages 20-40, with no history of pneumococcal vaccination Exclusion Criteria: * Subjects with a recent febrile illness * Known or suspected immune dysfunction, conditions associated with immunosuppression, and receipt of immunosuppressive chem...